Amberstone Biosciences

Laguna Hills, United States

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

Jan 2022

Series A

Biotechnology Health Care Medical

Top Investors

National Science FoundationSinovation VenturesCowin VentureViva BioInnovatorXiamen Changrong Investment Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amberstone Biosciences

Who are Amberstone Biosciences's investors?

Amberstone Biosciences's investors include National Science Foundation, Sinovation Ventures, Cowin Venture, Viva BioInnovator, Xiamen Changrong Investment Management.

Where is Amberstone Biosciences headquartered?

Amberstone Biosciences is headquartered in Laguna Hills, United States.

What does Amberstone Biosciences do?

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

What stage is Amberstone Biosciences at?

Amberstone Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 3, 2022.

MLA

"Amberstone Biosciences — Funding & Investors." VCBacked, January 3, 2022, https://www.vcbacked.co/company/amberstone-biosciences. Accessed July 1, 2026.

APA

VCBacked. (2022). Amberstone Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/amberstone-biosciences

Wikipedia (cite web)

{{cite web |title=Amberstone Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/amberstone-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 3, 2022.